en · de · es · fr · pt
aod-9604-notes.peptides6155.com › Blog › Identity And Research Context — Evidence Review

Identity And Research Context — Evidence Review

By Editorial Desk · published 2026-02-11 · last reviewed 2026-03-29 · Blog

human growth hormone is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2026-03-29. Numbers and descriptions here follow the published literature rather than marketing material.

Identity and Research Context

Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.

Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.

Regulatory and Analytical Context

In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.

Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.

Aod-9604 at a glance

PropertyValueNotes
Common nameAOD-9604Development code used in scientific literature.
Chemical classSynthetic peptideFragment of human growth hormone.
Amino acid length16 residuesMatches hGH region 176-191.
AppearanceWhite to off-white powderTypical lyophilized peptide solid.
SolubilitySoluble in waterDissolves in aqueous media; exact behavior depends on salt form.

Background and Development History

Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.

AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.

Related pages on this site

Identity and Molecular Context

Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.

AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.

The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.

Background from the literature

== Further reading == Arsenyeva KE (18 March 2007). "Опыт применения Фенотропила в клинической практике" [The Experience of Using Phenotropil in Clinical Practice] (HTML). РМЖ (Русский Медицинский Журнал) [RMS (Russian Medical Journal)] (in Russian) (6): 519. ISSN 2225-2282.

Medications for treatment of cases that do not improve include calcium channel blockers and iloprost. There is little evidence that alternative medicine reduce symptoms. Severe Raynaud's may in rare cases lead to complications, specifically skin sores or gangrene. About 4% of people have the condition. Onset of the primary form is typically between ages 15 and 30. The secondary form usually affects older people. Both forms are more common in cold climates.

However, those whose symptoms had remitted were significantly more likely to have good relationships with a romantic partner and at least one parent, good performance at work and school, a sustained work and school history, and good psychosocial functioning overall. Estimates of the lifetime risk of death by suicide among individuals with BPD range between 3% and 10%, varying with the method of investigation. In a study examining completed suicides among individuals aged 18 to 35, 30% of the suicides were attributed to people with BPD, with a majority being men, and almost none receiving treatment. Similar findings were reported in another study. Among men diagnosed with BPD, there is also evidence of a higher suicide rate: "men are more than twice as likely as women—18 percent versus 8 percent"—to die by suicide. There is evidence that a significant proportion of males who die by suicide may have undiagnosed BPD. About half of all individuals who commit suicide are diagnosed with a personality disorder, with BPD being the most common association.

As with all German armies on the Eastern Front, Hoepner's panzer group implemented the Commissar Order that directed Wehrmacht troops to murder Red Army political officers immediately upon capture, contravening the accepted laws of war. Between 2 July and 8 July, the 4th Panzer Group shot 101 Red Army political commissars, with the bulk of the executions coming from the XLI Panzer Corps. By 19 July, 172 executions of commissars had been reported. By mid-July, the 4th Panzer Group seized the Luga bridgehead and had plans to advance on Leningrad. The staff and detachments 2 and 3 of Einsatzgruppe A, one of the mobile killing squads following the Wehrmacht into the occupied Soviet Union, were brought up to the Luga district with assistance from the army. "The movement of Einsatzgruppe A—which the army intended to use in Leningrad—was effected in agreement with Panzer Group 4 and at their express wish", noted Franz Walter Stahlecker, the commander of Einsatzgruppe A. Stahlecker described army co-operation as "generally very good" and "in certain cases, as for example, with Panzer Group 4 under the command of General Hoepner, extremely close, one might say even warm". By late July, Army Group North positioned 4th Panzer Group's units south and east of Narva, Estonia, where they could begin an advance on Leningrad in terrain conditions relatively suitable for armoured warfare. By that time, however, the army group lacked the strength to take Leningrad, which continued to be a high priority for the German high command.

=== Cats === Paracetamol is extremely toxic to cats, which lack the necessary UGT1A6 enzyme to detoxify it. Initial symptoms include vomiting, salivation, and discoloration of the tongue and gums. Unlike an overdose in humans, liver damage is rarely the cause of death; instead, methemoglobin formation and the production of Heinz bodies in red blood cells inhibit oxygen transport by the blood, causing asphyxiation (methaemoglobinaemia and haemolytic anaemia). Acetylcysteine is used to treat cats with toxicity arising from paracetamol.

Sources: en.wikipedia.org

Reference notes

An alpha helix (or α-helix) is a sequence of amino acids in a protein that are twisted into a coil (a helix). The alpha helix is the most common structural arrangement in the secondary structure of proteins. It is also the most extreme type of local structure, and it is the local structure that is most easily predicted from a sequence of amino acids. The alpha helix has a right-handed helix conformation in which every backbone N−H group hydrogen bonds to the backbone C=O group of the amino acid that is four residues earlier in the protein sequence.

==== Irradiation ==== Food irradiation is another notable biological engineering process to achieve food safety. Research into the potential utilization of ionizing irradiation for food preservation started in the 1940s as an extension of studies on the effect of radiation on living cells. The FDA approved usage of ionizing radiation on food products in 1990. This radiation removes electrons from atoms, and these electrons go on to damage the DNA of microorganisms living in the food, killing the microorganisms. Irradiation can be used to pasteurize food products, such as seafood, poultry, and red meat, thus making these food products safer for consumers. Some irradiation is also used to delay fruit ripening processes, which can kill microorganisms that accelerate the ripening and spoilage of produce. Low dosages of radiation can also be used to kill insects living in harvested crops, as the radiation will stunt the insects' development at various stages and damage their ability to reproduce.

During the 19th century, following the discovery of the first tombs and artifacts in Egypt, egyptology became popular in Europe, especially in Victorian England. European aristocrats would occasionally entertain themselves by purchasing mummies, having them unwrapped, and holding observation sessions. The pioneer of this kind of entertainment in Britain was Thomas Pettigrew known as "Mummy" Pettigrew due to his work. Such unrolling sessions destroyed hundreds of mummies, because the exposure to the air caused them to disintegrate. While mummies were used in medicine, some researchers have brought into question these other uses such as making paper and paint, fueling locomotives and fertilizing land. The use of mummies as fuel for locomotives was documented by Mark Twain, likely humorously, but the truth of the story remains debatable. During the American Civil War, mummy-wrapping linens were said to have been used to manufacture paper. Evidence for the reality of these claims is still equivocal. Researcher Ben Radford reports that, in her book The Mummy Congress, Heather Pringle writes: "No mummy expert has ever been able to authenticate the story ... Twain seems to be the only published source – and a rather suspect one at that". Pringle also writes that there is no evidence for the "mummy paper" either. Radford says that many journalists have not done a good job with their research, and while it is true that mummies were often not shown respect in the 1800s, there is no evidence for this rumor.

== Eponym == Donohue syndrome was first identified in 1948 by Canadian pathologist William L. Donohue (1906–1985). The name leprechaunism has been largely abandoned because of the perception of the name by some parents of patients as insulting.

Human placental lactogen (hPL), also called human chorionic somatomammotropin (hCS) or human chorionic somatotropin, is a polypeptide placental hormone, the human form of placental lactogen (chorionic somatomammotropin). Its structure and function are similar to those of human growth hormone. It modifies the metabolic state of the mother during pregnancy to facilitate energy supply to the fetus. hPL has anti-insulin properties. hPL is a hormone secreted by the syncytiotrophoblast during pregnancy. Like human growth hormone, hPL is encoded by genes on chromosome 17q22-24. It was identified in 1963. Its two forms are encoded by the genes CSH1 and CSH2 and differ only by a single amino acid.

Sources: en.wikipedia.org

Frequently asked questions

What is AOD-9604?

AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.

Is AOD-9604 the same as human growth hormone?

No. It contains only a small portion of the human growth hormone sequence. The full hormone has 191 amino acids and many additional actions that the fragment does not share.

Why is it called hGH fragment 176-191?

The name refers to the amino acid positions in the human growth hormone chain. The fragment spans residues 176 through 191 at the C-terminal end. This naming convention helps distinguish it from full-length hGH.

Is AOD-9604 approved for medical use?

No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.

Network